Sign inJoin waitlistJoin the waitlist

CT

Christopher Tehlirian

Rheumatology

Credentials: · ·

History

Rheumatology
Internal Medicine

Research

TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial
Journal of Investigative Dermatology · 2020 · 94 citations
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised,…
The Lancet Rheumatology · 2021 · First of 13 authors · Corresponding · 28 citations
High-dose cyclophosphamide without stem cell rescue in scleroderma
Annals of the Rheumatic Diseases · 2008 · First of 5 authors · 25 citations

EP
Elena Peeva
4 papers
DP
David Pariser
1 paper
Fredrick Wigley
1 paper
JK
James Krueger
1 paper
Kaitlin Brunsvold
1 paper
Laura Hummers
1 paper
PW
Peter Winkle
1 paper
Robert Brodsky
1 paper
ST
Sanela Tarabar
1 paper
SF
Seth Forman
1 paper